|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/194 | (2006.01) |
| A61K 31/197 | (2006.01) | ||
| A61K 31/216 | (2006.01) | ||
| A61K 31/41 | (2006.01) | ||
| A61K 31/221 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/401 | (2006.01) | ||
| A61K 31/225 | (2006.01) | ||
| A61P 9/12 | (2006.01) | ||
| A61P 9/10 | (2006.01) |
| (11) | Number of the document | 4321157 |
| (13) | Kind of document | T |
| (96) | European patent application number | 23202190.7 |
| Date of filing the European patent application | 2014-08-26 | |
| (97) | Date of publication of the European application | 2024-02-14 |
| (45) | Date of publication and mention of the grant of the patent | 2024-10-23 |
| (46) | Date of publication of the claims translation | 2025-01-10 |
| (30) | Number | Date | Country code |
| PCT/US2013/056680 | 2013-08-26 | WO | |
| 201461972933 P | 2014-03-31 | US |
| (72) |
SHI, Victor Chengwei , US
LEFKOWITZ, Martin , US
RIZKALA, Adel Remond , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Naujas angiotenzino receptoriaus blokatoriaus (ARB) ir neutralios endopeptidazės inhibitoriaus (NEPI) derinio panaudojimas |
| NEW USE OF A COMBINATION OF AN ANGIOTENSIN RECEPTOR BLOCKER (ARB) WITH A NEUTRAL ENDOPEPTIDASE INHIBITOR (NEPI) |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 12 | 289.00 EUR |
| 2026-08-26 |